Lantheus Holdings, Inc.
USD111.16
+1.57 (+1.44%)
CEO
Mary Anne Heino
IPO Date
2015-06-25
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$109.80
Prev. Close
$109.58
Day Low
$109.00
Day High
$111.52
52W Low
$47.25
52W High
$111.52
Market Cap
$7.24B
Volume
0.14M
| 19.8 |
| 31 Dec 2023 | FY | 54.7% | 25.2% | 40.0% | 19.8% | 0.76 | 5.80 | 13.0 |
| 31 Dec 2022 | FY | 62.2% | 3.0% | 6.3% | 2.1% | 1.30 | 2.74 | 124.3 |
| 31 Dec 2021 | FY | 44.1% | -16.8% | -15.3% | -8.3% | 0.41 | 2.61 | -27.4 |
| 31 Dec 2020 | FY | 40.9% | -4.0% | -2.6% | -1.5% | 0.46 | 2.29 | -54.2 |
| 31 Dec 2019 | FY | 50.3% | 9.1% | 27.6% | 7.8% | 1.70 | 2.62 | 25.3 |
| 31 Dec 2018 | FY | 50.9% | 11.8% | 57.1% | 9.2% | 3.75 | 3.70 | 14.8 |
| 31 Dec 2017 | FY | 48.9% | 37.2% | 529.8% | 32.1% | 11.51 | 3.16 | 6.2 |
| 31 Dec 2016 | FY | 45.6% | 8.9% | -25.1% | 10.5% | -2.61 | 2.53 | 10.3 |
| 20.2 |
| 30 Sept 2025 | Q3 | 57.9% | 7.2% | 2.5% | 1.2% | 0.55 | 2.67 | 31.0 |
| 30 Jun 2025 | Q2 | 63.8% | 20.8% | 6.7% | 3.7% | 0.53 | 4.29 | 17.8 |
| 31 Mar 2025 | Q1 | 63.8% | 19.6% | 6.3% | 3.5% | 0.53 | 5.74 | 23.0 |
| 31 Dec 2024 | Q4 | 63.5% | -3.0% | -1.1% | -0.6% | 0.57 | 5.52 | -131.3 |
| 30 Sept 2024 | Q3 | 63.9% | 34.6% | 11.1% | 6.4% | 0.52 | 1.65 | 14.5 |
| 30 Jun 2024 | Q2 | 64.9% | 15.8% | 6.0% | 3.2% | 0.60 | 4.68 | 22.3 |
| 31 Mar 2024 | Q1 | 68.1% | 35.4% | 13.9% | 7.2% | 0.65 | 4.84 | 7.9 |
| 31 Dec 2023 | Q4 | 64.9% | 29.2% | 12.7% | 6.3% | 0.76 | 5.80 | 10.3 |